These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21867403)

  • 1. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?
    McCarthy JJ
    J Matern Fetal Neonatal Med; 2012 Feb; 25(2):109-12. PubMed ID: 21867403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Jansson L; Fischer G
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1197-201. PubMed ID: 22292518
    [No Abstract]   [Full Text] [Related]  

  • 3. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
    Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
    Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
    McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
    Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
    Blondell RD; Smith SJ; Servoss TJ; DeVaul SK; Simons RL
    J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
    Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
    Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.
    Isemann B; Meinzen-Derr J; Akinbi H
    J Perinatol; 2011 Jan; 31(1):25-9. PubMed ID: 20508596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
    Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Buprenorphine in pregnancy].
    Eder H; Rupp I; Peternell A; Fischer G
    Psychiatr Prax; 2001 Sep; 28(6):267-9. PubMed ID: 11533891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.
    Jones HE; Johnson RE; Jasinski DR; Milio L
    Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infants of drug-addicted mothers: pitfalls of replacement therapy].
    Vert P; Hamon I; Hubert C; Legagneur M; Hascoet JM
    Bull Acad Natl Med; 2008 May; 192(5):961-9; discussion 969. PubMed ID: 19238786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
    Fischer G; Ortner R; Rohrmeister K; Jagsch R; Baewert A; Langer M; Aschauer H
    Addiction; 2006 Feb; 101(2):275-81. PubMed ID: 16445556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale.
    Jones HE; O'Grady KE; Johnson RE; Velez M; Jansson LM
    Subst Use Misuse; 2010 Nov; 45(13):2244-57. PubMed ID: 20482340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.